glp 1 agonisten GLP-1 receptor agonists show promise in treating substance use disorders Resmetirom and GLP-1 agonists for

PCs have shown promising neuroprotective effects by reducing oxidative stress, preventing the accumulation of AGEs and other toxic intermediates, and mitigating glycation-induced damage

Tohkin, M

Cardiolipin can be oxidized by ROS or by the cardiolipincytochrome c complex ( c from cardiolipin might also be triggered by increased cytosolic calcium, which weakens the electrostatic interaction between cytochrome c and cardiolipin and further generates ROS via MPT

S-Acetyl Glutathione This is a chemically modified version of glutathione

with more progressive features including hypotension, bradycardia, tetany, drowsiness, respiratory depression and coma